Associations between pretreatment physical performance tests and treatment complications in patients with non-small cell lung cancer: A systematic review

Crit Rev Oncol Hematol. 2021 Feb:158:103207. doi: 10.1016/j.critrevonc.2020.103207. Epub 2020 Dec 28.

Abstract

This systematic review evaluated which outcome variables and cut-off values of pretreatment exercise tests are associated with treatment complications in patients with stage I-III non-small cell lung cancer (NSCLC). PRISMA and Cochrane guidelines were followed. A total of 38 studies with adult patients undergoing treatment for stage I-III NSCLC who completed pretreatment exercise tests, and of whom treatment-related complications were recorded were included. A lower oxygen uptake at peak exercise amongst several other variables on the cardiopulmonary exercise test and a lower performance on field tests, such as the incremental shuttle walk test, stair-climb test, and 6-minute walk test, were associated with a higher risk for postoperative complications and/or postoperative mortality. Cut-off values were reported in a limited number of studies and were inconsistent. Due to the variety in outcomes, further research is needed to evaluate which outcomes and cut-off values of physical exercise tests are most clinically relevant.

Keywords: Aerobic capacity; Lung cancer; Perioperative care; Prehabilitation; Preoperative risk assessment.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Carcinoma, Non-Small-Cell Lung* / complications
  • Carcinoma, Non-Small-Cell Lung* / diagnosis
  • Carcinoma, Non-Small-Cell Lung* / therapy
  • Exercise Test
  • Humans
  • Lung Neoplasms* / diagnosis
  • Lung Neoplasms* / therapy
  • Physical Functional Performance
  • Postoperative Complications / diagnosis
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology